Insights

Pre-care Opportunity Novir targets proactive, prevention-focused healthcare, presenting a potential upsell for early-detection services, wellness programs, and preemptive health management solutions to healthcare providers, employers, and health systems looking to shift from reactive care.

Biotech Partnerships With expertise in biotechnology research and a healthcare-driven mission, Novir could collaborate on clinical-stage trials, data analytics, and digital health integrations, offering co-development, contract research, or white-label platforms to pharma and biotech firms.

Tech Platform Fit Current tech stack (cloud, containerization, analytics readiness, and digital marketing) suggests readiness for hosted patient engagement platforms, telehealth integrations, and scalable data pipelines, enabling sales plays around SaaS solutions for prevention-focused care.

Market Expansion Active pursuit of early-stage preventive care aligns with growing demand for innovative health management; opportunities exist in selling to health plans, employers, and clinics seeking to reduce long-term costs through prevention and early intervention strategies.

Credible Messaging Recent clinical trial activity and a focused mission provide talking points for ROI-focused pitches around reduced hospitalization risk, improved population health metrics, and faster trial-to-market timelines, appealing to investors and partners seeking proven translational value.

Similar companies to Novir

Novir Tech Stack

Novir uses 8 technology products and services including QuickBooks, LinkedIn Recruiter, Amazon Web Services, and more. Explore Novir's tech stack below.

Media & News

Novir's Email Address Formats

Novir uses at least 3 email formats:
Novir Email FormatsExamplePercentage
First@novir-usa.comJohn@novir-usa.com
91%
First.Last@novir-usa.comJohn.Doe@novir-usa.com
6%
FLast@novir-usa.comJDoe@novir-usa.com
3%

Frequently Asked Questions

What is Novir's stock symbol?

Minus sign iconPlus sign icon
Novir is a publicly traded company; the company's stock symbol is NNVC.

What is Novir's official website and social media links?

Minus sign iconPlus sign icon
Novir's official website is novir-usa.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Novir generate?

Minus sign iconPlus sign icon
As of October 2026, Novir's annual revenue is estimated to be $25M - $50M.

What is Novir's SIC code and NAICS code?

Minus sign iconPlus sign icon
Novir's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Novir have currently?

Minus sign iconPlus sign icon
As of October 2026, Novir has approximately 40 employees across 2 continents, including North America and Asia. Key team members include Account Manager: H. P., Quality Assurance Manager: L. P. M. L. and Clinical Coordinator: A. C. Explore Novir's employee directory with LeadIQ.

What industry does Novir belong to?

Minus sign iconPlus sign icon
Novir operates in the Biotechnology Research industry.

What technology does Novir use?

Minus sign iconPlus sign icon
Novir's tech stack includes QuickBooks, LinkedIn Recruiter, Amazon Web Services, Docker, WordPress, CircleCI, Barracuda Email Protection and Google Cloud.

What is Novir's email format?

Minus sign iconPlus sign icon
Novir's email format typically follows the pattern of First@novir-usa.com. Find more Novir email formats with LeadIQ.

How much funding has Novir raised to date?

Minus sign iconPlus sign icon
As of October 2026, Novir has raised $3.9M in funding. The last funding round occurred on Sep 23, 2024 for $3.9M.

When was Novir founded?

Minus sign iconPlus sign icon
Novir was founded in 2020.
Novir logo

Novir

Biotechnology ResearchWisconsin, United States11-50 Employees

Novir is a biotechnology research company based in Milwaukee, Wisconsin, focused on shifting healthcare toward prevention. It seeks to preempt disease by enabling proactive health management through new services and technologies. The approach centers on starting care earlier, before a formal diagnosis, to build a pre-care pathway that individuals can access anywhere and anytime. Its target customers include individuals seeking to take charge of their health and healthcare systems looking to reduce late-stage interventions.

Within the biotechnology research field, Novir describes itself as a small-to-mid-sized company. Its location and mission place it in a context of advancing preventive health and proactive care.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
NNVC
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
11-50

Section iconFunding & Financials

  • $3.9M

    Novir has raised a total of $3.9M of funding over 1 rounds. Their latest funding round was raised on Sep 23, 2024 in the amount of $3.9M as a Debt Financing.

  • $25M - $50M

    Novir's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.